GeoPharma to launch desloratadine tablets
This article was originally published in The Tan Sheet
Executive Summary
GeoPharma can commercially launch a generic version of Schering Corp.'s Clarinex desloratadine tablets (5 mg) beginning July 2012, under a settlement agreement with Schering, Sepracor and the University of Massachusetts. "The new product launch may be a prescription or over-the-counter product depending on its status at the time of launch," Largo, Fla.-based GeoPharma notes in a Jan. 20 announcement. The company will have six months of marketing co-exclusivity to sell the allergy relief product. The settlement resolves all Hatch-Waxman litigation related to the desloratadine tablets triggered when GeoPharma filed paragraph IV certification for the product